Struman I - Search Results

1

The angiostatic protein 16K human prolactin significantly prevents tumor-induced lymphangiogenesis by affecting lymphatic endothelial cells.

Kinet V, Castermans K, Herkenne S, Maillard C, Blacher S, Lion M, Noël A, Martial JA, Struman I. Kinet V, et al. Among authors: struman i. Endocrinology. 2011 Nov;152(11):4062-71. doi: 10.1210/en.2011-1081. Epub 2011 Aug 23. Endocrinology. 2011. PMID: 21862622

2

Stabilization of T7-promoter-based pARHS expression vectors using the parB locus.

De Moerlooze L, Struman I, Renard A, Martial JA. De Moerlooze L, et al. Among authors: struman i. Gene. 1992 Sep 21;119(1):91-3. doi: 10.1016/0378-1119(92)90070-6. Gene. 1992. PMID: 1398095

3

Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin.

D'Angelo G, Struman I, Martial J, Weiner RI. D'Angelo G, et al. Among authors: struman i. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6374-8. doi: 10.1073/pnas.92.14.6374. Proc Natl Acad Sci U S A. 1995. PMID: 7541539 Free PMC article.

4

Evidence for a second receptor binding site on human prolactin.

Goffin V, Struman I, Mainfroid V, Kinet S, Martial JA. Goffin V, et al. Among authors: struman i. J Biol Chem. 1994 Dec 23;269(51):32598-606. J Biol Chem. 1994. PMID: 7798264 Free article.

5

The addition of nine residues at the C-terminus of human prolactin drastically alters its biological properties.

Goffin V, Struman I, Goormaghtigh E, Martial JA. Goffin V, et al. Among authors: struman i. Eur J Biochem. 1993 Jun 1;214(2):483-90. doi: 10.1111/j.1432-1033.1993.tb17945.x. Eur J Biochem. 1993. PMID: 8513798 Free article.

6

Inhibition of urokinase activity by the antiangiogenic factor 16K prolactin: activation of plasminogen activator inhibitor 1 expression.

Lee H, Struman I, Clapp C, Martial J, Weiner RI. Lee H, et al. Among authors: struman i. Endocrinology. 1998 Sep;139(9):3696-703. doi: 10.1210/endo.139.9.6194. Endocrinology. 1998. PMID: 9724020 Free article.

7

Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis.

Struman I, Bentzien F, Lee H, Mainfroid V, D'Angelo G, Goffin V, Weiner RI, Martial JA. Struman I, et al. Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1246-51. doi: 10.1073/pnas.96.4.1246. Proc Natl Acad Sci U S A. 1999. PMID: 9990009 Free PMC article.

8

The antiangiogenic factor 16K PRL induces programmed cell death in endothelial cells by caspase activation.

Martini JF, Piot C, Humeau LM, Struman I, Martial JA, Weiner RI. Martini JF, et al. Among authors: struman i. Mol Endocrinol. 2000 Oct;14(10):1536-49. doi: 10.1210/mend.14.10.0543. Mol Endocrinol. 2000. PMID: 11043570 Free article.

9

Expression of the antiangiogenic factor 16K hPRL in human HCT116 colon cancer cells inhibits tumor growth in Rag1(-/-) mice.

Bentzien F, Struman I, Martini JF, Martial J, Weiner R. Bentzien F, et al. Among authors: struman i. Cancer Res. 2001 Oct 1;61(19):7356-62. Cancer Res. 2001. PMID: 11585777 Free article.

10

The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappaB.

Tabruyn SP, Sorlet CM, Rentier-Delrue F, Bours V, Weiner RI, Martial JA, Struman I. Tabruyn SP, et al. Among authors: struman i. Mol Endocrinol. 2003 Sep;17(9):1815-23. doi: 10.1210/me.2003-0132. Epub 2003 Jun 5. Mol Endocrinol. 2003. PMID: 12791771

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters